BioMarin to Participate in Two Virtual Investor Conferences in January

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) has announced that its CEO, Jean-Jacques Bienaimé, will present at two virtual investor conferences in January 2022. The webcasts of these events will be accessible through their investor relations webpage, with archived versions available for a limited time post-conference. BioMarin focuses on developing therapies for serious rare disorders, currently offering seven commercialized products and several candidates in various stages of clinical development. For more information, visit their official website.

BioMarin to Present at Two Investor Conferences in January 2022

SAN RAFAEL, Calif., Jan. 4, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at two virtual conferences in January. To access the live webcasts, please visit: https://investors.biomarin.com/.  An archived version of the presentations will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

###

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-virtual-investor-conferences-in-january-301452837.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

What will BioMarin present at the investor conferences in January 2022?

BioMarin will present insights and updates from their CEO, Jean-Jacques Bienaimé, at two virtual investor conferences.

Where can I access the live webcasts for BioMarin's January 2022 presentations?

The live webcasts for BioMarin's presentations can be accessed on their investor relations website.

How many commercial products does BioMarin have?

BioMarin currently has seven commercialized products in its portfolio.

When are the investor conferences that BioMarin will participate in?

The investor conferences are scheduled for January 2022.

What is the stock symbol for BioMarin?

The stock symbol for BioMarin Pharmaceutical is BMRN.